How policymakers are seeking to contain drug spending

There is no doubt that drug shortages are a detriment to the pharma supply chain, but how commonplace were they during the COVID era?

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.

The latest news for pharma industry insiders.

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

The deal further grows the Big Pharma company’s US production capabilities, especially when it comes to global parenteral products.

The latest news for pharma industry insiders.